EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Characterizing proximal risk for depressive symptoms and suicidal ideation with acute cannabis use and withdrawal among adolescents using ecological momentary assessment: Study protocol

Isabella Feibus iD, Marta Borrego Mahiques, Meghan Costello, Kevin Potter, Kate H Bentley, Bettina B Hoeppner, Luwei Liu, Bryn Evohr, Lynn Yan, Jodi Gilman, A Eden Evins, Joe Kossowsky und 1 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0338790 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Isabella Feibus und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Depression, Ecological Momentary Assessment, Marijuana Abuse, Substance Withdrawal Syndrome. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, National Institutes of Health, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heavy cannabis use often co-occurs with symptoms of depression in adolescents. Adolescents with past-year cannabis use are at increased risk of major depressive episodes and cannabis use is more than twice as common in adolescents with depression compared to those without. This study seeks to disentangle relationships between acute cannabis use, withdrawal, and abstinence on proximal depression and suicide risk using ecological momentary assessment (EMA) within the context of a randomized controlled trial comparing the effects of cannabis abstinence to cannabis use as usual.

Methods

This study will enroll 200 adolescents aged 12–18 who have daily or near-daily cannabis use and current depressive symptoms. Participants will complete 12 study visits over a 10-week period. At visit 2, participants will be randomized (1:1) to either 8 weeks of sustained cannabis abstinence encouraged through contingency management (CB-Abst) or a monitoring control group (CB-Mon). All participants will complete self-report and interview-based measures of substance use and symptom severity, along with 3 phases of EMA data collection (4 total weeks), involving 8 daily surveys that inquire about past-hour substance use, mood, and situational context. Phases will take place during baseline cannabis use, immediately after randomized abstinence, and following 8 weeks of sustained abstinence. The primary outcomes will be EMA-measured depressive symptoms and suicidal ideation across the 3 EMA phases, by randomized group. Exploratory outcomes will include Fitbit-derived measures of sleep, circadian rhythms, and step count.

Discussion

This is the first study, to our knowledge, to evaluate the acute effects of cannabis use, withdrawal, and sustained abstinence on mood among adolescents with heavy cannabis use and co-morbid symptoms of depression. Results will characterize periods of risk for fluctuations in mood and suicidal ideation across the withdrawal period and aim to guide intervention development to reduce depression and suicide risk among adolescents.

Trial registration

ClinicalTrials.gov NCT06576076

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionEcological Momentary AssessmentMarijuana AbuseSubstance Withdrawal SyndromeSuicidal IdeationAdolescentChildFemaleHumansMaleCannabisRisk FactorsRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America.
  • Department of Anesthesia, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Division of Sleep Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.

ORCID-Profile: Isabella Feibus, Randi M Schuster

Förderung

  • NIDA NIH HHS
  • National Institutes of Health
  • National Institute on Drug Abuse

Zitieren

APA

Feibus, I., Mahiques, M. B., Costello, M., Potter, K., Bentley, K. H., Hoeppner, B. B., Liu, L., Evohr, B., Yan, L., Gilman, J., Evins, A. E., Kossowsky, J., & Schuster, R. M. (2025). Characterizing proximal risk for depressive symptoms and suicidal ideation with acute cannabis use and withdrawal among adolescents using ecological momentary assessment: Study protocol. PLOS One. https://doi.org/10.1371/journal.pone.0338790

Vancouver

Feibus I, Mahiques MB, Costello M, Potter K, Bentley KH, Hoeppner BB, et al. Characterizing proximal risk for depressive symptoms and suicidal ideation with acute cannabis use and withdrawal among adolescents using ecological momentary assessment: Study protocol. PLOS One. 2025. doi:10.1371/journal.pone.0338790

BibTeX
@article{Feibus2025,
  author = {Feibus, Isabella and Mahiques, Marta Borrego and Costello, Meghan and Potter, Kevin and Bentley, Kate H and Hoeppner, Bettina B and Liu, Luwei and Evohr, Bryn and Yan, Lynn and Gilman, Jodi and Evins, A Eden and Kossowsky, Joe and Schuster, Randi M},
  title = {Characterizing proximal risk for depressive symptoms and suicidal ideation with acute cannabis use and withdrawal among adolescents using ecological momentary assessment: Study protocol},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0338790}
}
Kostenlos starten →